What do yoga, a happy hour office crawl, an all-day hackathon, and a 70-mile bus ride have in common?
A core tenet of Xconomy—and the reason behind our broad coverage across information technology, life sciences, energy, and more—is that the most interesting and important innovations often arise from the intersection of different disciplines.
One of the most important intersections today... Read more »
Keep up with the latest news from Wisconsin’s innovation community with these recent headlines:
Think “innovation” and you might picture some scrappy entrepreneurs toiling away in a kitchen or garage, hoping the landlord doesn’t notice what they’re up to. But the reality is that turning science into big business often requires far more sophisticated infrastructure—and... Read more »
StartingBlock Madison, a still-to-be-built entrepreneurial center just east of downtown in Wisconsin’s capital city, took another major step forward this week. The nonprofit organization says it has met its $3 million fundraising goal and, with that piece in place, can... Read more »
Arrowhead Pharmaceuticals has initiated a Phase 2 clinical trial for its drug candidate aimed at treating rare liver diseases associated with alpha-1 antitrypsin (AAT) deficiency, the company said on Tuesday.
AAT deficiency is a genetic disorder that involves mutation of the... Read more »
Stay current on the latest news from Wisconsin’s innovation community, starting with these recent headlines:
—Mallinckrodt finalized its acquisition of Madison-based Stratatech, which is developing cell-based human skin tissue for treating burn wounds, the Wisconsin State Journal reported. Mallinckrodt (NYSE: MNK),... Read more »
Ultrafast broadband is increasingly a must-have for high-tech companies, especially those in telemedicine, 3D printing, and other emerging industries. But currently, connection speeds vary widely by location—states like Tennessee are home to cities that have built high-speed fiber Internet networks while other... Read more »
CEO of Zero Locus
Baird Capital operating partner
President and CEO of Bridge to Cures
Medical College of Wisconsin director of research commercialization
Managing partner of HealthX Ventures
President and CEO of BrightStar Wisconsin Foundation
CEO of Exact Sciences
Director, Genome Center, University of Wisconsin-Madison; Principal Investigator, Lloyd Smith Research Group, University of Wisconsin-Madison; Chemistry Professor, University of Wisconsin-Madison
Executive director of the Milwaukee Institute
President, Marquette University